Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY33.00 CNY
Change Today -2.35 / -6.65%
Volume 6.4M
As of 3:00 AM 07/30/15 All times are local (Market data is delayed by at least 15 minutes).

grandhope biotech co ltd-a (300238) Snapshot

Open
CNY34.70
Previous Close
CNY35.35
Day High
CNY35.29
Day Low
CNY33.00
52 Week High
06/12/15 - CNY63.10
52 Week Low
01/6/15 - CNY22.03
Market Cap
8.2B
Average Volume 10 Days
7.9M
EPS TTM
CNY0.21
Shares Outstanding
247.0M
EX-Date
04/16/15
P/E TM
161.0x
Dividend
CNY0.05
Dividend Yield
0.15%
Current Stock Chart for GRANDHOPE BIOTECH CO LTD-A (300238)

Related News

No related news articles were found.

grandhope biotech co ltd-a (300238) Related Businessweek News

No Related Businessweek News Found

grandhope biotech co ltd-a (300238) Details

Grandhope Biotech Co., Ltd., a bio-tech company, develops, manufactures, and markets regenerative medical devices for the treatment of damaged tissue and organs in China. The company offers GrandNeuro membrane, an artificial dura patch for dura repairing; and NormalGEN, a type of biological dura repair patch manufactured from animal tissue used for the closure of dura mater during neurosurgery. It also provides ThormalGEN, a biological surgical patch manufactured from animal tissue for surgical repairs; and DermalGEN, a wound dressing product manufactured from animal tissue for use on burns, scalds, and wounds due to skin loss or trauma. In addition, the company is involved in the research and development of various products in the areas of menbranes, conduits, bones and ligament, and collagens. Grandhope Biotech Co., Ltd. was founded in 1999 and is headquartered in Guangzhou, China.

Founded in 1999

grandhope biotech co ltd-a (300238) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

grandhope biotech co ltd-a (300238) Key Developments

Guanhao Biotech Co., Ltd.(SZSE:300238) added to Shenzhen Stock Exchange Component A Share Index

Guanhao Biotech Co., Ltd. has been added to Shenzhen Stock Exchange Component A Share Index.

Guanhao Biotech Co., Ltd.(SZSE:300238) added to Shenzhen Stock Exchange Component Index

Guanhao Biotech Co., Ltd. has been added to Shenzhen Stock Exchange Component Index.

Guanhao Biotech Co., Ltd., Special/Extraordinary Shareholders Meeting, May 15, 2015

Guanhao Biotech Co., Ltd., Special/Extraordinary Shareholders Meeting, May 15, 2015., at 15:00 China Standard Time. Agenda: To consider the nomination of independent director candidates, accumulative voting system applicable; to consider the nomination of Wei Jianguo as independent director candidate; and to consider the nomination of Fu Qilin as independent director candidate.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
300238:CH CNY33.00 CNY -2.35

300238 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 300238.
View Industry Companies
 

Industry Analysis

300238

Industry Average

Valuation 300238 Industry Range
Price/Earnings 100.0x
Price/Sales 44.3x
Price/Book 15.7x
Price/Cash Flow 160.7x
TEV/Sales 40.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GRANDHOPE BIOTECH CO LTD-A, please visit www.grandhopebio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.